Philogen S.p.a.

Laura Gualandi

Sarah Wulhfard

Alessandra Villa

Roberto De Luca

Francesca Pretto

Mattia Matasci

Rajesh Kamath

Annette Schwartz Sterman

Catherine Hutchinson

Catherine Pemberton-Ross

The present application relates to specific binding members that bind carbonic anhydrase IX (CAIX). In particular, the present application relates to the treatment, diagnosis and detection of tumours, e.g. solid tumours, using specific binding members that bind CAIX. The specific binding member may be conjugated to a biocidal or cytotoxic molecule, or to a detectable label.

Antibodies to tumour antigens

The invention relates to the diagnosis and treatment of diseases, including cancer and inflammatory disorders. The invention provides, and involves the use of, antibodies that bind collagen.

Anti-collagen antibodies for treatment and diagnosis

The invention relates to the diagnosis and treatment of diseases, including cancer and inflammatory disorders. The invention provides, and involves the use of, antibodies that bind: i) the IIICS isoform of fibronectin, ii) matrix-metalloproteinase 3 (MMP3), iii) periostin, or iv) tenascin-W.

Antibodies for treatment and diagnosis

Growing community of inventors

Zurich, Switzerland

Laura Gualandi